Monday, March 10, 2014

CBD (Cannabidiol) Use For Chrohn's Disease and Colitis

Cannabidiol in inflammatory bowel diseases: a brief overview.


This minireview highlights the importance of cannabidiol (CBD) as a promising drug for the therapy of inflammatory bowel diseases (IBD). Actual pharmacological treatments for IBD should be enlarged toward the search for low-toxicityand low-cost drugs that may be given alone or in combination with the conventional anti-IBD drugs to increase their efficacy in the therapy of relapsing forms of colitis. In the past, Cannabis preparations have been considered new promising pharmacological tools in view of their anti-inflammatory role in IBD as well as other gut disturbances. However, their use in the clinical therapy has been strongly limited by their psychotropic effects. CBD is a very promising compound since it shares the typical cannabinoid beneficial effects on gut lacking any psychotropic effects. For years, its activity has been enigmatic for gastroenterologists and pharmacologists, but now it is evident that this compound may interact at extra-cannabinoid system receptor sites, such as peroxisome proliferator-activated receptor-gamma. This strategic interaction makes CBD as a potential candidate for the development of a new class of anti-IBD drugs.

Cannabidiol reduces intestinal inflammation through the control of neuroimmune axis.


Enteric glial cells (EGC) actively mediate acute and chronic inflammation in the gut; EGC proliferate and release neurotrophins, growth factors, and pro-inflammatory cytokines which, in turn, may amplify the immune response, representing a very important link between the nervous and immune systems in the intestine. Cannabidiol (CBD) is an interesting compound because of its ability to control reactive gliosis in the CNS, without any unwanted psychotropic effects. Therefore the rationale of our study was to investigate the effect of CBD on intestinal biopsies from patients with ulcerative colitis (UC) and from intestinal segments of mice with LPS-induced intestinal inflammation. CBD markedly counteracted reactive enteric gliosis in LPS-mice trough the massive reduction of astroglial signalling neurotrophin S100B. Histological, biochemical and immunohistochemical data demonstrated that S100B decrease was associated with a considerable decrease in mast cell and macrophages in the intestine of LPS-treated mice after CBD treatment. Moreover the treatment of LPS-mice with CBD reduced TNF-α expression and the presence of cleaved caspase-3. Similar results were obtained in ex vivo cultured human derived colonic biopsies. In biopsies of UC patients, both during active inflammation and in remission stimulated with LPS+INF-γ, an increased glial cell activation and intestinal damage were evidenced. CBD reduced the expression of S100B and iNOS proteins in the human biopsies confirming its well documented effect in septic mice. The activity of CBD is, at least partly, mediated via the selective PPAR-gamma receptor pathway. CBD targets enteric reactive gliosis, counteracts the inflammatory environment induced by LPS in mice and in human colonic cultures derived from UC patients. These actions lead to a reduction of intestinal damage mediated by PPARgamma receptor pathway. Our results therefore indicate that CBD indeed unravels a new therapeutic strategy to treat inflammatory bowel diseases.

Cannabidiol, a safe and non-psychotropic ingredient of the marijuana plant Cannabis sativa, is protective in a murine model of colitis.


Inflammatory bowel disease affects millions of individuals; nevertheless, pharmacological treatment is disappointingly unsatisfactory. Cannabidiol, a safe and non-psychotropic ingredient of marijuana, exerts pharmacological effects (e.g., antioxidant) and mechanisms (e.g., inhibition of endocannabinoids enzymatic degradation) potentially beneficial for the inflamed gut. Thus, we investigated the effect of cannabidiol in a murine model of colitis. Colitis was induced in mice by intracolonic administration of dinitrobenzene sulfonic acid. Inflammation was assessed both macroscopically and histologically. In the inflamed colon, cyclooxygenase-2 and inducible nitric oxide synthase (iNOS) were evaluated by Western blot, interleukin-1beta and interleukin-10 by ELISA, and endocannabinoids by isotope dilution liquid chromatography-mass spectrometry. Human colon adenocarcinoma (Caco-2) cells were used to evaluate the effect of cannabidiol on oxidative stress. Cannabidiol reduced colon injury, inducible iNOS (but not cyclooxygenase-2) expression, and interleukin-1beta, interleukin-10, and endocannabinoid changes associated with 2,4,6-dinitrobenzene sulfonic acid administration. In Caco-2 cells, cannabidiol reduced reactive oxygen species production and lipid peroxidation. In conclusion, cannabidiol, a likely safe compound, prevents experimental colitis in mice.

Topical and systemic cannabidiol improves trinitrobenzene sulfonic acid colitis in mice.



Compounds of Cannabis sativa are known to exert anti-inflammatory properties, some of them without inducing psychotropic side effects. Cannabidiol (CBD) is such a side effect-free phytocannabinoid that improves chemically induced colitis in rodents when given intraperitoneally. Here, we tested the possibility whether rectal and oral application of CBD would also ameliorate colonic inflammation, as these routes of application may represent a more appropriate way for delivering drugs in human colitis.


Colitis was induced in CD1 mice by trinitrobenzene sulfonic acid. Individual groups were either treated with CBD intraperitoneally (10 mg/kg), orally (20 mg/kg) or intrarectally (20 mg/kg). Colitis was evaluated by macroscopic scoring, histopathology and the myeloperoxidase (MPO) assay.


Intraperitoneal treatment of mice with CBD led to improvement of colonic inflammation. Intrarectal treatment with CBD also led to a significant improvement of disease parameters and to a decrease in MPO activity while oral treatment, using the same dose as per rectum, had no ameliorating effect on colitis.


The data of this study indicate that in addition to intraperitoneal application, intrarectal delivery of cannabinoids may represent a useful therapeutic administration route for the treatment of colonic inflammation.

CBD is now legal and available in all 50 States in America.

You Can get a Great Overview Here


Zanne Bech said...

everything Cannabidiol can do for you.....hypnosis can do. Without sideeffects. Call for info 323 318 4755

Jeff1974 said...

In what county can you suggest treatment of a physical illness with hypnosis?

lee woo said...

The gospel comprises indeed, and unfolds, the whole mystery of man's redemption, as far forth as it is necessary to be known for our salvation. See the link below for more info.


Willson Rou said...

This is really useful stuff .I have never had an idea about this, will look for more of such informative posts from your side related to CBD Products .. Good job...

Ally Hrovatt said...

I love the fact this information is coming to the surface. Enough pharma meds,... nature has the solution with absolutely no side effects. CBD oil is the cure. Many people report 100% success with it.

joy said...

Reading your article is such a privilege. It does inspire me, I hope that you can share more positive thoughts. Visit my site too. The link is posted below.

Octavio Johnson said...

There are health and wellness benefits of the cannabis plant in Cannabidiol.

Bharath Gopalan said...

This post is likeable, and your blog is very interesting, congratulations.

Genious Person said...

You know your projects stand out of the herd. There is something special about them. It seems to me all of them are really brilliant! buycannabidiol

Anonymous said...

Wow i can say that this is another great article as expected of this blog.Bookmarked this site.. cbd oilscanada

Jones Morris said...

I have read your blog it is very helpful for me. I want to say thanks to you. I have bookmark your site for future updates. cbd vape juice

Elizabeth J. Neal said...

thanks for this usefull article, waiting for this article like this again.
buy cbd oil

jenifer thomas said...

After starting the treatment if you're suffering from some significant side effects like fever, pulse rate changes, greater blood pressure you should right away quit using it or inform your physician. cbdspray org

william smith said...

CBD or Cannabidiol to use the complete name is made of the Hemp plant.Source for more about wherecanigetcbdoil.

Mia02p said... may be used for sleeping disorders, too, but as stated, the dose ought to be on the decrease side initially.

Muhammad robart said...

you want to provide them of the correct dosage they require from cannabis.Learn about cbdforsale on

Arpita mehra said...
This comment has been removed by the author.
Annabella maxton said...

100 % Pure Cbd for Dog - the Conspiracy CBD products are a safe, non-toxic option for pet parents who would like a more transparent treatment alternative for their dog. Author is an expert of cbddrops, click here for more interesting information.

Arpita mehra said...

CBD has various benefits such because it will provide you relaxation. has various tutorials related to wherecanibuycannabisoil.

joseph taxton said...

Our office will contact your insurance business to attain pre-certification on health related on دكتور جراحة عامة.

mangkimay said...

My partner and I absolutely love your blog and find many of your post’s to be exactly what I’m looking for.
mesin bakso
mesin mie
oven roti
harga deep fryer
mesin kopi
thanks a lot my bro

Elizabeth J. Neal said...

I wanted to thank you for this great read!! I definitely enjoying every little bit of it I have you bookmarked to check out new stuff you post. CBD Oil Drops

eddy shaw said...

very nice submit, i actually love this website, keep on it online casino

Alex said...

Crohn thank you for your nice article, Yes i am agree with you CBD products are a safe and toxic free.

Panggang Ayam Marketing said...